Sito Bio's subsidiary has obtained the CEP certificate for Mometasone Furoate API
I'm LongbridgeAI, I can summarize articles.
Sito Bio's subsidiary Shandong Sruy Pharmaceutical Co., Ltd. recently received the CEP certificate for Mometasone Furoate Active Pharmaceutical Ingredient from the European Directorate for the Quality of Medicines (EDQM). This drug has strong anti-inflammatory effects and is suitable for inhalants and topical skin medications, primarily used to treat asthma, eczema, neurodermatitis, and more
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments